Cleared Traditional

K002089 - ROSETTA-LT/ROSETTA-RX

K002089 is an FDA 510(k) clearance for ROSETTA-LT/ROSETTA-RX, manufactured by General Devices. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K002089 · General Devices · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2000
Decision
133d
Days
Class 2
Risk

K002089 is an FDA 510(k) clearance for the ROSETTA-LT/ROSETTA-RX. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by General Devices (Ridgefield, US). The FDA issued a Cleared decision on November 21, 2000 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all General Devices devices

FDA 510(k) Submission Details - K002089

510(k) Number K002089 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 2000
Decision Date November 21, 2000
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 155
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K002089.
HEALTH BUDDY APPLIANCE
K050567 · Health Hero Network, Inc. · Apr 2005
RTX3320PSTN WIRELESS TELEHEALTH GATEWAY
K041816 · Rtx Healthcare A/S · Jul 2004
THE M3810A PHILIPS TELEMONITORING SYSTEM WITH M3812B TELESTATION (M310A/12B)
K023749 · Philips Medical Systems · Nov 2002
MPT 24 AND VITAL VIEW 24
K000276 · Criticare Systems, Inc. · Mar 2000
AVIVA SYSTEM, MODEL SL1010
K993550 · American Telecare, Inc. · Jan 2000
MODIFICATION OF: PHYSIOLOGICAL SIGNAL TRANSMITTER AND RECEIVER, MODEL 3810A
K993169 · Hewlett-Packard Co. · Dec 1999